HB 111 Delaware House · 151st General Assembly (2021-2022)

AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO INSURANCE DISCRIMINATION BASED ON PRE-EXPOSURE PROPHYLAXIS MEDICATION TO PREVENT HIV INFECTION.

Summary

Individuals who are at very high risk of getting HIV can take pre-exposure prophylaxis (“PrEP”) medication to reduce the risk of HIV transmission. PrEP medication reduces the risk of HIV transmission by up to 99% if taken daily. This Act prohibits discrimination because an individual takes PrEP medication in the issuance or renewal of disability, long-term care, and life insurance.

Bill status signed all 5 stages cleared

Introduction

Feb 2021

Committee Review

May 2021

House Passage

Mar 2021

Senate Passage

May 2021

Signed into Law

Jun 2021

Introduced Feb 19, 2021 Signed Jun 15, 2021

Floor votes · Senate May 19, 2021 · House Mar 30, 2021

How they voted

20–0

Passed

Total votes 20

May 19, 2021

D Democratic13

13 Yea

100% Yea

R Republican7

7 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 15, 2021

Signed into law

Signed by Governor

executive

May 19, 2021

Upper · Passed

Passed By Senate. Votes: 21 YES

upper

May 13, 2021

Upper · Passed

Reported Out of Committee (Banking, Business & Insurance) in Senate with 5 On Its Merits

upper

Mar 30, 2021

Introduced

Assigned to Banking, Business & Insurance Committee in Senate

upper

Mar 30, 2021

Lower · Passed

Passed By House. Votes: 41 YES

lower

Mar 16, 2021

Lower · Passed

Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 4 Favorable, 5 On Its Merits

lower

Feb 19, 2021

Introduced

Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

lower

4 primary · 7 co-sponsors